Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

AvKARE Silodosin Capsules Recalled for Subpotency

Agency Publication Date: February 20, 2025
Share:
Sign in to monitor this recall

Summary

AvKARE is voluntarily recalling 1,266 bottles of Silodosin (8mg) capsules, a prescription medication used to treat symptoms of an enlarged prostate. Testing revealed that the drug was subpotent, meaning it contained less than the required amount of active ingredient (94.9% vs the required minimum of 95.0%) and an impurity level slightly above specifications. The recall affects 90-count bottles manufactured by Amneal Pharmaceuticals of NY for AvKARE.

Risk

Because this medication is subpotent, it may not be fully effective in treating urinary symptoms associated with an enlarged prostate. There is also a small increase in a specific impurity, which could potentially affect the quality and safety of the medication over time.

What You Should Do

  1. This recall affects AvKARE Silodosin Capsules, 8mg, sold in 90-count bottles with NDC 42291-778-90, Lot number BC20223A, and an expiration date of March 31, 2025.
  2. If you have health concerns regarding the use of this medication, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact AvKARE for further instructions.
  3. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Silodosin Capsules (90-count bottle)by AvKARE
Variants: 8mg, Rx only
Lot Numbers:
BC20223A (Exp. March 31, 2025)
NDC:
42291-778-90

Manufactured for AvKare by Amneal Pharmaceuticals of NY, LLC

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96247
Status: Active
Manufacturer: AvKARE
Manufactured In: United States
Units Affected: 1266 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.